Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
W Zhao, C Xie, X Zhang, J Liu, J Liu… - Brain and Behavior, 2023 - Wiley Online Library
Introduction Epilepsy is one of the most common and serious brain syndromes and has
adverse consequences on a patient's neurobiological, cognitive, psychological, and social …
adverse consequences on a patient's neurobiological, cognitive, psychological, and social …
The role of mitochondria in phytochemically mediated disease amelioration
Mitochondrial dysfunction may cause cell death, which has recently emerged as a cancer
prevention and treatment strategy mediated by chemotherapy drugs or phytochemicals …
prevention and treatment strategy mediated by chemotherapy drugs or phytochemicals …
Bee venom ameliorates oxidative stress and histopathological changes of hippocampus, liver and testis during status epileptics
EK Aly, HS Mahmoud, DHM Alkhalifah, GMG Shehab… - Neuropeptides, 2023 - Elsevier
The unrelenting progression of neurodegenerative diseases has a negative impact on
affected individuals, their families, and society. Recurrent epileptic seizures are the hallmark …
affected individuals, their families, and society. Recurrent epileptic seizures are the hallmark …
Pharmacometabolic Effects of Pteryxin and Valproate on Pentylenetetrazole-Induced Seizures in Zebrafish Reveal Vagus Nerve Stimulation
A Skiba, D Pellegata, V Morozova, E Kozioł… - Cells, 2023 - mdpi.com
Zebrafish (Danio rerio) assays provide a versatile pharmacological platform to test
compounds on a wide range of behaviors in a whole organism. A major challenge lies in the …
compounds on a wide range of behaviors in a whole organism. A major challenge lies in the …
Fluimucil as a neuroprotective, is there anything new? Bibliometric study from 1996 to 2024
AY SALEH, TD Susanto, R Valentina… - …, 2025 - f1000research.com
Introduction Fluimucil, also known as N-acetylcysteine (NAC), has been used as a medicinal
drug for treating Alzheimer's and Parkinson's disease. Recent research has shown NAC's …
drug for treating Alzheimer's and Parkinson's disease. Recent research has shown NAC's …
1400 W, a selective inducible nitric oxide synthase inhibitor, mitigates early neuroinflammation and nitrooxidative stress in diisopropylfluorophosphate-induced short …
Organophosphate nerve agent (OPNA) exposure induces acute and long-term neurological
deficits. OPNA exposure at sub-lethal concentrations induces irreversible inhibition of …
deficits. OPNA exposure at sub-lethal concentrations induces irreversible inhibition of …